Show simple item record

dc.contributor.authorZetsche, Bernd
dc.contributor.authorAbudayyeh, Omar O.
dc.contributor.authorGootenberg, Jonathan S
dc.contributor.authorScott, David Arthur
dc.contributor.authorZhang, Feng
dc.date.accessioned2022-01-06T14:32:23Z
dc.date.available2021-12-08T18:03:18Z
dc.date.available2022-01-06T14:32:23Z
dc.date.issued2020
dc.identifier.urihttps://hdl.handle.net/1721.1/138386.2
dc.description.abstract© 2019 by The Keio Journal of Medicine. The class 2 CRISPR-Cas endonuclease Cas12a (previously known as Cpf1) offers several advantages over Cas9, including the ability to process its own array and the requirement for just a single RNA guide. These attributes make Cas12a promising for many genome engineering applications. To further expand the suite of Cas12a tools available, we tested 16 Cas12a orthologs for activity in eukaryotic cells. Four of these new enzymes demonstrated targeted activity, one of which, from Moraxella bovoculi AAX11_00205 (Mb3Cas12a), exhibited robust indel formation. We also showed that Mb3Cas12a displays some tolerance for a shortened PAM (TTN versus the canonical Cas12a PAM TTTV). The addition of these enzymes to the genome editing toolbox will further expand the utility of this powerful technology.en_US
dc.description.sponsorshipNational Institutes of Health (Grants 1R01-HG009761, 1R01-MH110049 and 1DP1-HL141201)en_US
dc.language.isoen
dc.publisherKeio Journal of Medicineen_US
dc.relation.isversionof10.2302/KJM.2019-0009-OAen_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourceKeio Journal of Medicineen_US
dc.titleA Survey of Genome Editing Activity for 16 Cas12a Orthologsen_US
dc.typeArticleen_US
dc.identifier.citationZetsche, Bernd, Abudayyeh, Omar O, Gootenberg, Jonathan S, Scott, David A and Zhang, Feng. 2020. "A Survey of Genome Editing Activity for 16 Cas12a Orthologs." The Keio Journal of Medicine, 69 (3).en_US
dc.contributor.departmentBroad Institute of MIT and Harvarden_US
dc.contributor.departmentMcGovern Institute for Brain Research at MITen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Brain and Cognitive Sciencesen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.relation.journalThe Keio Journal of Medicineen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2021-12-08T17:58:18Z
dspace.orderedauthorsZetsche, B; Abudayyeh, OO; Gootenberg, JS; Scott, DA; Zhang, Fen_US
dspace.date.submission2021-12-08T17:58:19Z
mit.journal.volume69en_US
mit.journal.issue3en_US
mit.licenseOPEN_ACCESS_POLICY
mit.metadata.statusPublication Information Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

VersionItemDateSummary

*Selected version